Here are relevant reports on : contract-analytics-market
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API, FDF), Packaging & Labelling, Fill-finish), Molecule (Small, Large (ADC, CGT)) - Global Forecast to 2030
The global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Software Asset Management Market by Solutions (License Management, Audit & Compliance Management, Software Discovery, Optimization, & Metering, Contract Management, Configuration Management) - Global Forecast to 2029
The software asset management market is projected to reach USD 7.3 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 16.0% during the forecast period. Some of the key players operating in the software asset management market are – Flexera (US), Snow Software(Sweden), USU Software AG(Germany), Ivanti(US), BMC Software(US), ServiceNow(US), Certero(UK), Matrix42(Germany), Broadcom(US), and Eracent(US).
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029
The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
EV Assembly Market by Manufacturing Strategy (Gigacasting, Smart Factory), Platform Type (Dedicated, Modular, Integrated), EV Component, Integration Type (In-house, Outsourced, Contract Manufacturing), OEM Analysis, and Region - Global Forecast to 2035
The EV assembly market is projected to grow from USD 190.11 billion in 2026 to USD 291.39 billion by 2035, at a CAGR of 4.9%. The major players in the EV assembly market include Tesla (US), BYD Company Ltd. (China), VOLKSWAGEN AG (Germany), Geely Auto (China), and Hyundai Motor Company (South Korea).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Offshore Drilling Market by Service (Contract Drilling, Directional Drilling, Logging While Drilling, and Measurement While Drilling), by Application (Shallow, Deep, and Ultra-Deep Water) & by Region - Global Forecast to 2020
Offshore drilling includes services related to drilling wells including type of the rig required, depth and direction of well to be dug and services and expertise required to accomplish the desired goal. Offshore drilling market is estimated to be $78.57 Billion in 2014 and is projected to grow with a CAGR of 4.54% from 2015 to 2020. Crude oil prices which have witnessed a sharp decline in the last one year are expected to increase to USD 80/ barrel by 2018. This rebound in oil price will be spurred by the delay in capacity addition as the oil & gas companies are currently shelving new projects to reduce their capital expenditure. With the increase in the price of crude oil, the investments for E&P activities will also increase which will lead to new projects in regions that are looking to overturn their production decline such as Europe and Asia-Pacific. This will in turn create further demand for the offshore drilling in these regions.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Medical Device Manufacturing Equipment (by Production) Market by Type (Material Processing, Sterilization & Cleaning Equipment), Application (Consumables & Disposables), End User (OEMs, Contract Manufacturing Organizations) - Global Forecast to 2030
The global medical device manufacturing equipment market is projected to reach USD 27.80 billion by 2030, growing at a CAGR of 7.6% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
FinTech Blockchain Market by Provider, Application (Payments, Clearing, and Settlement, Exchanges and Remittance, Smart Contract, Identity Management, and Compliance Management/KYC), Organization Size, Vertical, and Region - Global Forecast to 2023
The FinTech blockchain market is expected to grow from USD 370.3 Million in 2018 to USD 6,228.2 Million by 2023, at a Compound Annual Growth Rate (CAGR) of 75.9% during the forecast period. The major drivers of the FinTech blockchain market include the higher compatibility with financial industry ecosystem, the rising crypto-currency market cap and Initial Coin Offering (ICO), faster transaction, and reduced total cost of ownership. The future growth opportunities for FinTech blockchain market include the rising adoption of blockchain applications, such as payments, clearing, and settlements, smart contracts, and identity management, and a new breed of programmable blockchain platform. The major FinTech blockchain technology vendors include AWS (US), IBM (US), Microsoft (US), Ripple (US), Chain (US), Earthport (UK), Bitfury (US), BTL Group (Canada), Oracle (US), Digital Asset Holdings (US), Circle (Ireland), Factom (US), AlphaPoint (US), Coinbase (US), Abra (US), Auxesis Group (India), BitPay (US), BlockCypher (US), Applied Blockchain (UK), RecordesKeeper (Spain), Symbiont (US), Guardtime (Estonia), Cambridge Blockchain (US), Tradle (US), and Blockchain Advisory Mauritius Foundation (Mauritius).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
